CerebraMed Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

CerebraMed General Information


Operator of a pharmaceutical company for the treatment of Alzheimer's disease. The company offers a medicinal treatment for patients with Alzheimer's disease to slow down or halt the damage to the brain's nerve cells. The company has developed proprietary GSK-3 inhibitors as drug candidates.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Drug Delivery
Primary Office
  • Tel Aviv
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CerebraMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 03-Feb-2016 Completed Startup
To view CerebraMed’s complete valuation and funding history, request access »

CerebraMed Executive Team (1)

Name Title Board Seat Contact Info
Hagit Eldar-Finkelman Ph.D Founder
To view CerebraMed’s complete executive team members history, request access »

CerebraMed Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Brainnovations Accelerator/Incubator 000 0000 000000 0
To view CerebraMed’s complete investors history, request access »